Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Niva Bupa Health Insurance Company Ltd

NIVABUPA
NSE
78.75
2.27%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Alert
Watchlist
Note

Niva Bupa Health Insurance Company Ltd

NIVABUPA
NSE
78.75
2.27%
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
14,549Cr
Close
Close Price
78.75
Industry
Industry
Finance - Insurance
PE
Price To Earnings
PS
Price To Sales
2.44
Revenue
Revenue
5,961Cr
Rev Gr TTM
Revenue Growth TTM
17.37%
PAT Gr TTM
PAT Growth TTM
-105.03%
Peer Comparison
How does NIVABUPA stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
NIVABUPA
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
1,0148529921,0331,3191,1591,3601,2411,5651,3081,5381,550
Growth YoY
Revenue Growth YoY%
42.533.830.036.137.120.118.612.913.124.9
Expenses
ExpensesCr
8708659691,0211,1521,1361,3011,2371,4701,4541,6001,685
Operating Profit
Operating ProfitCr
144-1323121672358395-145-62-136
OPM
OPM%
14.2-1.62.31.112.62.04.30.36.1-11.1-4.0-8.8
Other Income
Other IncomeCr
117172189230304277320315357324334386
Interest Expense
Interest ExpenseCr
000000000000
PBT
PBTCr
39-72-85157-191313206-91-35-88
Tax
TaxCr
000000000000
PAT
PATCr
39-72-85157-191313206-91-35-88
Growth YoY
PAT Growth YoY%
-2,363.3-403.6302.273.9271.5189.131.2-385.9-370.9-761.9
NPM
NPM%
3.9-8.5-0.80.411.9-1.61.01.113.2-7.0-2.3-5.7
EPS
EPS
0.00.00.00.00.00.00.00.11.1-0.5-0.2-0.5

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
2,1123,1614,1965,3245,961
Growth
Revenue Growth%
49.732.726.911.9
Expenses
ExpensesCr
2,9233,9915,0156,2276,209
Operating Profit
Operating ProfitCr
-811-829-819-903-248
OPM
OPM%
-38.4-26.2-19.5-17.0-4.2
Other Income
Other IncomeCr
03642181421,400
Interest Expense
Interest ExpenseCr
00000
PBT
PBTCr
-1971382214-8
Tax
TaxCr
00000
PAT
PATCr
-1971382214-8
Growth
PAT Growth%
106.4552.7160.9-103.9
NPM
NPM%
-9.30.41.94.0-0.1
EPS
EPS
-1.40.10.51.20.0

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Dec 2025
Equity Capital
Equity CapitalCr
1,4091,5111,7001,8270
Reserves
ReservesCr
-903-6831,2831,9490
Borrowings
BorrowingsCr
2502502502500
Other Liabilities
Other LiabilitiesCr
00-932-7180
Total Liabilities
Total LiabilitiesCr
7561,0782,3013,3080
Fixed Assets
Fixed AssetsCr
59750
Advances
AdvancesCr
2293535321,289
Cash Equivalents
Cash EquivalentsCr
591021432200
Other Assets
Other AssetsCr
4686231,5671,7230
Total Assets
Total AssetsCr
7561,0782,3013,3080

Cash Flow

Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
3385938131,654
Investing Cash Flow
Investing Cash FlowCr
-723-829-1,882-2,348
Financing Cash Flow
Financing Cash FlowCr
3742801,110771
Net Cash Flow
Net Cash FlowCr
-12434178
Free Cash Flow
Free Cash FlowCr
3095557801,613
CFO To PAT
CFO To PAT%
-171.94,724.6992.9774.7
CFO To EBITDA
CFO To EBITDA%
-41.6-71.5-99.2-183.2

Ratios

Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
00014,253
Price To Earnings
Price To Earnings
0.00.00.066.7
Price To Sales
Price To Sales
0.00.00.02.6
Price To Book
Price To Book
0.00.00.04.7
EV To EBITDA
EV To EBITDA
-0.2-0.2-0.1-15.8
Profitability Ratios
Profitability Ratios
OPM
OPM%
-38.4-26.2-19.5-17.0
NPM
NPM%
-9.30.41.94.0
ROCE
ROCE%
-26.01.22.55.3
ROE
ROE%
-38.91.52.75.7
ROA
ROA%
-26.01.23.66.5
Solvency Ratios
Solvency Ratios
Niva Bupa Health Insurance Company Limited (formerly Max Bupa) is a premier standalone health insurer (SAHI) in India. Operating as a subsidiary of **Bupa Singapore Holdings Pte Ltd** (holding **55.36%**), the company has transitioned from a high-growth startup phase into a scaled, profitable enterprise. As the **3rd largest retail health insurer** in India, Niva Bupa commands a **10.2% retail market share** (as of **Q3 FY26**) and is a primary beneficiary of India’s under-penetrated health insurance sector. --- ### **Strategic Market Positioning & Product Architecture** Niva Bupa employs a data-driven, customer-centric strategy focused on **Lifetime Value (LTV)**. Its product suite is segmented to capture the entire demographic spectrum of the Indian market: * **The Flagship "ReAssure" Series:** * **ReAssure 2.0 & 3.0:** Features "Lock the Clock" (premiums fixed to entry age until a claim is made) and "ReAssure Forever" (unlimited base sum restoration). * **ReAssure 3.0 Innovations:** Includes **Wellconsult+** (OPD benefits up to **₹1 Lakh**) and **Safeguard+** (coverage for non-payable medical items). * **High-Net-Worth (HNI) Segment:** **Health Premia** and **NivaBupaOne** offer coverage up to **₹5 Crores** with international coverage for major illnesses and significant OPD limits. * **The "Missing Middle" & Rural Expansion:** The **Rise** product (launched **Feb 2025**) targets Tier III/IV cities with **Flexi-Pay** monthly installments and a **50% Premium Return** feature. * **Next-Gen & Specialized Coverage:** * **Aspire/Elixir:** Targets Millennials/Gen Z with **M-iracle** (covering maternity, IVF, and adoption) and **Cash-bag** rewards. * **Senior First:** Tailored for senior citizens with an industry-first **2-hour hospitalization** feature. --- ### **Omni-Channel Distribution & Network Scale** The company utilizes a "new store" and "same-store" sales approach to maintain a retail business **CAGR target of 17%-18%**. | Channel | Scale & Reach (as of 9M FY26) | | :--- | :--- | | **Individual Agents** | **224,810** agents; added **15,000** in **Q3 FY26** alone. | | **Bancassurance** | **116** partners, including **HDFC Bank, Axis Bank, and Bank of Baroda**. | | **Brokers** | **575+** partners, including major digital platforms like **PolicyBazaar**. | | **Physical Footprint** | **210+** branches and **400+** locations across India. | | **Direct-to-Consumer** | Contributes **10-13%** of total business. | **Provider Network:** Niva Bupa manages medical inflation through a **Preferred Partner Network (PPN)** active in **43** cities across **~600** hospitals, offering ambulance services and relationship managers. The total empanelled network exceeds **10,587** hospitals. --- ### **Digital Ecosystem & "Intelligent Automation"** Niva Bupa is transitioning from a traditional insurer to a "health partner" through its **Niva Bupa Health App** (**1.23 crore+ downloads**; **5.7 lakh MAU**). * **Underwriting & Issuance:** **99.9%** of new policies are digital; **51%** of retail policies are auto-decisioned via rule-based engines. * **Claims Revolution:** **28.6%** of cashless claims are processed via **Auto-Adjudication**, reducing pre-authorization time from **30 minutes** to under **2 minutes**. * **Renewals:** **91.6%** of renewals are completed without human intervention. * **Health Services:** The app facilitates **6,000+** monthly doctor consults and **50,000+** monthly health checkups. --- ### **Financial Performance & Operational Metrics** The company listed in **November 2024**, raising **₹2,200 crore** (including **₹800 crore** fresh issue) to bolster solvency. **Key Financial Indicators (9M FY26 vs. 9M FY25 - IFRS):** * **Gross Written Premium (GWP):** **₹5,706 Cr** (Reported) / **₹6,309 Cr** (Like-to-Like, **+25.9%**). * **Profit After Tax (PAT):** **₹208 Cr** (up **74%** YoY). * **Combined Ratio (COR):** Improved to **102.9%** (down **50 bps**). * **Solvency Ratio:** Robust at **3.03x** (as of March 2025), well above the **1.50x** mandate. * **Expense of Management (EOM):** Improved to **35%** from **39%** YoY. **Accounting Note:** Effective **Oct 1, 2024**, the company adopted **1/n accounting**, recognizing premiums proportionately over the policy duration. This resulted in a technical decrease in reported GWP of **₹644.5 Cr** for FY25 but does not impact underlying cash flows. --- ### **Regulatory Tailwinds & Industry Catalysts** * **GST Reform:** The reduction of GST on retail health insurance from **18% to 0%** (late 2025) is a "secular win." Niva Bupa observed a **15% increase in retail ticket size** as customers reinvested tax savings into higher sum insured plans. * **Bima Sugam:** The company invested **₹5.00 Cr** in this centralized digital marketplace to drive long-term penetration. * **FDI & Licensing:** Proposed **100% FDI** and **Composite Licenses** may allow for future capital inflows and multi-line expansion. --- ### **Risk Factors & Mitigation Framework** Niva Bupa operates under a **three lines of defence** model to manage the following: * **Regulatory Compliance:** The company has historically exceeded **EOM** limits (**39.22%** vs **35.55%** limit in FY25). Forbearance for the most recent year is pending. A **Show Cause Notice** was issued by IRDAI in **Feb 2026** regarding operational aspects. * **Tax Litigations:** Significant outstanding demands exist, including **₹127.16 Cr** in Income Tax (AY 2020-24) and a remanded **₹124.13 Cr** GST case regarding co-insurance commissions. * **Medical Inflation:** Retail claim costs have a **7.0% CAGR** since FY19. The company mitigates this through periodic price revisions (e.g., **7%** hike on ReAssure 2.0 in **Q1 FY26**). * **Cybersecurity:** Following threats in late 2024 and early 2025, the company has implemented independent impact assessments and enhanced data security protocols. * **Labor Costs:** Implementation of **New Labour Codes** in **Nov 2025** added a one-time cost of **₹19.92 Cr** for gratuity and leave encashment.